視源股份(002841.SZ):擬投資9億元建總部擴建項目
格隆匯10月15日丨視源股份(002841.SZ)公佈,2021年10月15日,公司召開了第四屆董事會第九次會議,審議通過了《關於投資擴建總部暨簽署投資協議的議案》,會議同意公司以自有或自籌資金投資人民幣9億元建設“視源股份總部擴建項目”,用於開展公司主要技術和產品的基礎研究,通過進一步擴建總部研發中心,以期鞏固和提升公司總部科研成果轉化能力和產品創新實力;並同意授權公司管理層與廣州開發區投資促進局簽署《視源股份總部擴建項目投資合作協議》。同日,公司與廣州開發區投資促進局簽署了本協議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.